MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
批准号:
2063668
负责人:
Jerry Saul Wolinsky
金额:
$21.95万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-06-01 至 1994-12-31
关键词:
Rubivirus SDS polyacrylamide gel electrophoresis affinity chromatography cellular immunity congenital infection drug adverse effect enzyme linked immunosorbent assay gel electrophoresis glycoproteins human tissue hybridomas iatrogenic disease immunofluorescence technique immunoprecipitation laboratory mouse mass spectrometry molecular pathology monoclonal antibody multiple sclerosis protein sequence rheumatoid arthritis rubellas subacute sclerosing panencephalitis tissue /cell culture viral vaccines virus infection mechanism virus protein western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our ultimate goal is to determine how aberrant immune responses to
rubella virus contribute to the clinical and pathological
manifestations of the congenital rubella syndrome, progressive
rubella panencephalitis, vaccine arthralgia and perhaps rheumatoid
arthritis and multiple sclerosis. A prerequisite is the
construction of the molecular topography of the antigenic domains
of rubella virus which elicit humoral and cell-mediated immune
responses. This will provide the required data base to define the
predicted alterations in the human immune response which contribute
to the diverse complications of rubella. This project will define
the minimum domains of rubella virus that are required to induce
antibody responses which interrupt virus infectivity, and those
amino acid sequences of the structural proteins which are processed
and presented by human monocytes to establish cellular immunity.
A library of monoclonal antibodies to rubella virus will be
expanded and used to define both sequential and conformation-
dependant antigen bearing domains residing on the structural
polypeptides. These experiments will utilize novel approaches
which combine the power of immunoprecipitation, antibody protected
partial proteolytic digestion, SDS-PAGE and fast atom bombardment
mass spectrometry. In vitro proliferative assays which use
polypeptides or their fragments bound to particulate nitrocellulose
will define antigenic domains recognized by immune cells. Selected
synthetic oligopeptides will confirm the importance of these
domains and provide reagents with which to probe critical
differences between normal and anomalous responses in rubella
related syndromes. The knowledge gained will increase our
understanding of normal immune responses to this common human
pathogen, provide critical information of use in constructing
molecularly engineered vaccines, facilitate the approach of others
to this general problem, and provide better insight into aberrant
human immune responses and their contribution to viral persistence
and virus-induced immunopathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
-
批准号:6309226
-
项目类别:
-
资助金额:$1.11万
-
财政年份:1999
-
负责人:Jerry Saul Wolinsky
-
依托单位:
HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
-
批准号:6121136
-
项目类别:
-
资助金额:$1.51万
-
财政年份:1998
-
负责人:Jerry Saul Wolinsky
-
依托单位:
AVONEX IN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS
-
批准号:6265662
-
项目类别:
-
资助金额:$1.11万
-
财政年份:1998
-
负责人:Jerry Saul Wolinsky
-
依托单位:
COPAXONE IN PATIENTS WITH MULTIPLE SCLEROSIS--OPEN LABEL STUDY
-
批准号:6252238
-
项目类别:
-
资助金额:$1.67万
-
财政年份:1997
-
负责人:Jerry Saul Wolinsky
-
依托单位:
SAFETY OF TIZANIDINE IN PATIENTS WITH MS--OPEN LABEL EVALUATION
-
批准号:6281660
-
项目类别:
-
资助金额:$1.36万
-
财政年份:1997
-
负责人:Jerry Saul Wolinsky
-
依托单位:
HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
-
批准号:6281706
-
项目类别:
-
资助金额:$1.36万
-
财政年份:1997
-
负责人:Jerry Saul Wolinsky
-
依托单位:
SAFETY OF TIZANIDINE IN PATIENTS WITH MS--OPEN LABEL EVALUATION
-
批准号:6252239
-
项目类别:
-
资助金额:$1.67万
-
财政年份:1997
-
负责人:Jerry Saul Wolinsky
-
依托单位:
COPAXONE IN PATIENTS WITH MULTIPLE SCLEROSIS--OPEN LABEL STUDY
-
批准号:6281659
-
项目类别:
-
资助金额:$1.36万
-
财政年份:1997
-
负责人:Jerry Saul Wolinsky
-
依托单位:
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
-
批准号:3141043
-
项目类别:
-
资助金额:$19.73万
-
财政年份:1989
-
负责人:Jerry Saul Wolinsky
-
依托单位:
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
-
批准号:3141047
-
项目类别:
-
资助金额:$19.53万
-
财政年份:1989
-
负责人:Jerry Saul Wolinsky
-
依托单位:
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
-
批准号:3141046
-
项目类别:
-
资助金额:$19.0万
-
财政年份:1989
-
负责人:Jerry Saul Wolinsky
-
依托单位:
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
-
批准号:3141048
-
项目类别:
-
资助金额:$21.14万
-
财政年份:1989
-
负责人:Jerry Saul Wolinsky
-
依托单位:
MOLECULAR IMMUNE RESPONSE DETERMINANTS OF RUBELLA VIRUS
-
批准号:2063669
-
项目类别:
-
资助金额:$9.0万
-
财政年份:1989
-
负责人:Jerry Saul Wolinsky
-
依托单位:
IMMUNOGLOBULIN ACCESS TO NEOANTIGENS ON CNS CELLS
-
批准号:3400679
-
项目类别:
-
资助金额:$13.45万
-
财政年份:1983
-
负责人:Jerry Saul Wolinsky
-
依托单位:
IMMUNOGLOBULIN ACCESS TO NEOANTIGENS ON CNS CELLS
-
批准号:3400678
-
项目类别:
-
资助金额:$12.7万
-
财政年份:1983
-
负责人:Jerry Saul Wolinsky
-
依托单位:
OPEN LABEL STUDY TO EVALUATE THE SAFETY OF TIZANIDINE IN PATIENTS WITH MS
-
批准号:5224095
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jerry Saul Wolinsky
-
依托单位:--
SAFETY OF TIZANIDINE IN PATIENTS WITH MS--OPEN LABEL EVALUATION
-
批准号:6121090
-
项目类别:
-
资助金额:$1.51万
-
财政年份:--
-
负责人:Jerry Saul Wolinsky
-
依托单位:
FAMPRIDINE THERAPY OF CHRONIC FIXED DEFICITS IN MULTIPLE SCLEROSIS
-
批准号:5224094
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jerry Saul Wolinsky
-
依托单位:--
EFFICACY AND SAFETY OF COPOLYMER I IN PATIENTS WITH MULTIPLE SCLEROSIS
-
批准号:3788653
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jerry Saul Wolinsky
-
依托单位:
EFFICACY AND SAFETY OF COPOLYMER I IN PATIENTS WITH MULTIPLE SCLEROSIS
-
批准号:3766542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Jerry Saul Wolinsky
-
依托单位: